Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases

A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and p-nitrophenyl acetate ( p-NpAc). The trifluoroketones used were very potent “transition state” inhi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical pharmacology 1987-06, Vol.36 (12), p.1869-1879
Hauptverfasser: Ashour, Mohamed-Bassem A., Hammock, Bruce D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1879
container_issue 12
container_start_page 1869
container_title Biochemical pharmacology
container_volume 36
creator Ashour, Mohamed-Bassem A.
Hammock, Bruce D.
description A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and p-nitrophenyl acetate ( p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e. K m, V max and ( T 1 2 ) e ] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.
doi_str_mv 10.1016/0006-2952(87)90483-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77560388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006295287904837</els_id><sourcerecordid>14798980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</originalsourceid><addsrcrecordid>eNqFkUuLFDEURoMoY9v6DxRqIaJgaVJJ57EZkMEXDLhQVy7CTXKD0apKm6QG599bbTe91FVIvnMfnBDymNFXjDL5mlIq-8HshudavTBUaN6rO2TDtOLrs9R3yeaM3CcPav1xuGrJLsgF3xnOjdmQb58XV1tqS8PQtZLiuOSSf2LLM9YOarfPDef2sqs4om_pBrs0f08utVxql2M3wTTBmGDuPBSXf9-OWBsWqFgfknsRxoqPTueWfH339svVh_760_uPV2-uey8kbz0TBoBKz51RkXonjDJBRKFcgEil4NrDID1yH2CAiM4BhiGo6ECFgUa-Jc-Offcl_1rW8XZK1eM4wox5qVapnaRc6_-CTCijjaYrKI6gL7nWgtHuS5qg3FpG7UG-Pai0B7NWK_tXvlVr2ZNT_8VNGM5FJ9tr_vSUQ_UwxgKzT_WMKcmMWMktuTxiuEq7SVhs9QlnjyGV9Q9syOnfe_wBAlej3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14798980</pqid></control><display><type>article</type><title>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ashour, Mohamed-Bassem A. ; Hammock, Bruce D.</creator><creatorcontrib>Ashour, Mohamed-Bassem A. ; Hammock, Bruce D.</creatorcontrib><description>A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and p-nitrophenyl acetate ( p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e. K m, V max and ( T 1 2 ) e ] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(87)90483-7</identifier><identifier>PMID: 3593399</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; carboxylesterase ; Carboxylic Ester Hydrolases - antagonists &amp; inhibitors ; Chemical and industrial products toxicology. Toxic occupational diseases ; Ketones - pharmacology ; Kinetics ; liver ; Malathion - pharmacology ; Medical sciences ; Mice ; Microsomes, Liver - enzymology ; Nitrophenols - pharmacology ; Species Specificity ; Structure-Activity Relationship ; Succinates - pharmacology ; Swine ; Toxicology ; trifluoroketone ; Various organic compounds</subject><ispartof>Biochemical pharmacology, 1987-06, Vol.36 (12), p.1869-1879</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</citedby><cites>FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0006295287904837$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7619493$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3593399$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ashour, Mohamed-Bassem A.</creatorcontrib><creatorcontrib>Hammock, Bruce D.</creatorcontrib><title>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and p-nitrophenyl acetate ( p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e. K m, V max and ( T 1 2 ) e ] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>carboxylesterase</subject><subject>Carboxylic Ester Hydrolases - antagonists &amp; inhibitors</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Ketones - pharmacology</subject><subject>Kinetics</subject><subject>liver</subject><subject>Malathion - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microsomes, Liver - enzymology</subject><subject>Nitrophenols - pharmacology</subject><subject>Species Specificity</subject><subject>Structure-Activity Relationship</subject><subject>Succinates - pharmacology</subject><subject>Swine</subject><subject>Toxicology</subject><subject>trifluoroketone</subject><subject>Various organic compounds</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUuLFDEURoMoY9v6DxRqIaJgaVJJ57EZkMEXDLhQVy7CTXKD0apKm6QG599bbTe91FVIvnMfnBDymNFXjDL5mlIq-8HshudavTBUaN6rO2TDtOLrs9R3yeaM3CcPav1xuGrJLsgF3xnOjdmQb58XV1tqS8PQtZLiuOSSf2LLM9YOarfPDef2sqs4om_pBrs0f08utVxql2M3wTTBmGDuPBSXf9-OWBsWqFgfknsRxoqPTueWfH339svVh_760_uPV2-uey8kbz0TBoBKz51RkXonjDJBRKFcgEil4NrDID1yH2CAiM4BhiGo6ECFgUa-Jc-Offcl_1rW8XZK1eM4wox5qVapnaRc6_-CTCijjaYrKI6gL7nWgtHuS5qg3FpG7UG-Pai0B7NWK_tXvlVr2ZNT_8VNGM5FJ9tr_vSUQ_UwxgKzT_WMKcmMWMktuTxiuEq7SVhs9QlnjyGV9Q9syOnfe_wBAlej3g</recordid><startdate>19870615</startdate><enddate>19870615</enddate><creator>Ashour, Mohamed-Bassem A.</creator><creator>Hammock, Bruce D.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19870615</creationdate><title>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</title><author>Ashour, Mohamed-Bassem A. ; Hammock, Bruce D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-149aa06c3b97f0cb4979d4f47bdaf06438ca26ce3cda2afebbaed2d7fba7d20f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>carboxylesterase</topic><topic>Carboxylic Ester Hydrolases - antagonists &amp; inhibitors</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Ketones - pharmacology</topic><topic>Kinetics</topic><topic>liver</topic><topic>Malathion - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microsomes, Liver - enzymology</topic><topic>Nitrophenols - pharmacology</topic><topic>Species Specificity</topic><topic>Structure-Activity Relationship</topic><topic>Succinates - pharmacology</topic><topic>Swine</topic><topic>Toxicology</topic><topic>trifluoroketone</topic><topic>Various organic compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ashour, Mohamed-Bassem A.</creatorcontrib><creatorcontrib>Hammock, Bruce D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ashour, Mohamed-Bassem A.</au><au>Hammock, Bruce D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1987-06-15</date><risdate>1987</risdate><volume>36</volume><issue>12</issue><spage>1869</spage><epage>1879</epage><pages>1869-1879</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>A series of substituted trifluoroketones were tested as inhibitors of mammalian liver microsomal carboxylesterase(s) hydrolyzing a variety of substrates including malathion, diethylsuccinate (DES) and p-nitrophenyl acetate ( p-NpAc). The trifluoroketones used were very potent “transition state” inhibitors of crude mouse and human liver microsomal carboxylesterases as well as commercial porcine liver carboxylesterase (Sigma EC 3.1.1.1 Type I). These enzymes were found to differ in their sensitivity to the inhibitors employed, and some compounds caused dramatic activation of the hydrolysis of DES. In some but not all cases, a thioether beta to the carbonyl increased the inhibitory potency of the compound. Structure-activity relationships also were evaluated among aliphatic versus substituted and unsubstituted aromatic trifluoroketones. Kinetic parameters [i.e. K m, V max and ( T 1 2 ) e ] for the mouse liver microsomes and the porcine carboxylesterase hydrolyzing DES were determined. Apparent high-and low-affinity forms were observed with each preparation. 3-Nonylthio-1,1,1-trifluoropropan-2-one was synthesized by the reaction of the corresponding thiol with 3-bromo-1,1,1-trifluoroacetone, and apparent synergism was observed when it was coadministered i.p. with malathion to mice.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>3593399</pmid><doi>10.1016/0006-2952(87)90483-7</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-2952
ispartof Biochemical pharmacology, 1987-06, Vol.36 (12), p.1869-1879
issn 0006-2952
1873-2968
language eng
recordid cdi_proquest_miscellaneous_77560388
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biological and medical sciences
carboxylesterase
Carboxylic Ester Hydrolases - antagonists & inhibitors
Chemical and industrial products toxicology. Toxic occupational diseases
Ketones - pharmacology
Kinetics
liver
Malathion - pharmacology
Medical sciences
Mice
Microsomes, Liver - enzymology
Nitrophenols - pharmacology
Species Specificity
Structure-Activity Relationship
Succinates - pharmacology
Swine
Toxicology
trifluoroketone
Various organic compounds
title Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substituted%20trifluoroketones%20as%20potent,%20selective%20inhibitors%20of%20mammalian%20carboxylesterases&rft.jtitle=Biochemical%20pharmacology&rft.au=Ashour,%20Mohamed-Bassem%20A.&rft.date=1987-06-15&rft.volume=36&rft.issue=12&rft.spage=1869&rft.epage=1879&rft.pages=1869-1879&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(87)90483-7&rft_dat=%3Cproquest_cross%3E14798980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14798980&rft_id=info:pmid/3593399&rft_els_id=0006295287904837&rfr_iscdi=true